References:
  1. Standards of medical care in diabetes — 2009. American Diabetes Association. Diabetes Care. 2009;32 Suppl 1:S13-61.
  2. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group (2008) Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med. 2008;359(14):1464-1476.
  3. Garg S, Zisser H, Schwartz S, et al. Improvement in glycemic excursions with a transcutaneous, real-time continuous glucose sensor: a randomized controlled trial. Diabetes Care. 2006;29(1):44-50.
  4. Garg SK, Kelly WC, Voelmle MK, et al. Continuous home monitoring of glucose: improved glycemic control with real-life use of continuous glucose sensors in adult subjects with type 1 diabetes. Diabetes Care. 2007;30(12):3023-3025.
  5. Garg S, Jovanovic L. Relationship of fasting and hourly blood glucose levels to HbA1c values: safety, accuracy, and improvements in glucose profiles obtained using a 7-day continuous glucose sensor. Diabetes Care. 2006;29(12):2644-2649.
  6. Brauker JH, Edelman SV. The function of continuous glucose sensors: How and why seeing glucose as a function of time enables proactive management decisions to avoid highs and lows. Rev Endo. May 2007.
  7. Hirsch IB. Glycemic variability: it's not just about A1C anymore! Diabetes Technol Ther. 2005;7(5):780-783.
  8. Hirsch IB, Brownlee M. The effect of glucose variability on the risk of microvascular complications in type 1 diabetes. Diabetes Care. 2007;30(1):186-187.
  9. Gerich JE, Odawara M, Terauchi Y. The rationale for paired pre- and postprandial self-monitoring of blood glucose: the role of glycemic variability in micro- and macrovascular risk. Curr Med Res Opin. 2007;23(8):1791-1798.
  10. Each payor and plan has their own set of criteria that must be met. DexCom can provide information on current coverage decisions.